Wealth Enhancement Advisory Services’s Palisade Bio PALI Stock Holding History
Bought
Maintained
Sold
Other funds holding PALI
BGI
Wealth Enhancement Advisory Services's PALI Position: Q3 2026 in Review
Wealth Enhancement Advisory Services reduced its Palisade Bio (PALI) stake by 41% in Q3 2026, selling an estimated $23.4K and leaving 17,235 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #4106.
Wealth Enhancement Advisory Services first reported a position in PALI in Q2 2026 and has held it in 2 quarters since. The position peaked at $33.2K in Q2 2026. 116 funds tracked by Wall St. Rank hold PALI as of Q3 2026.
- Wealth Enhancement Advisory Services held 17,235 shares of Palisade Bio worth $25K as of Q3 2026.
- Wealth Enhancement Advisory Services sold 11,993 Palisade Bio shares in Q3 2026, an estimated $23.4K.
- Palisade Bio made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #4106 holding.
- Wealth Enhancement Advisory Services first reported a position in Palisade Bio in Q2 2026 and has held it in 2 quarters since.
- Wealth Enhancement Advisory Services's Palisade Bio position peaked at $33.2K in Q2 2026.
- 116 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.